Nisa Investment Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Nisa Investment Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.4K	Buy	725 +620	+590%	+$32.2K	﹤0.01%	1887
2026 Q1	$5.06K	Hold	105	–	–	﹤0.01%	2453
2025 Q4	$4.33K	Hold	105	–	–	﹤0.01%	2479
2025 Q3	$4.08K	Hold	105	–	–	﹤0.01%	2481
2025 Q2	$2.9K	Sell	105 -49	-32%	-$1.25K	﹤0.01%	2537
2025 Q1	$3.42K	Sell	154 -90	-37%	-$1.85K	﹤0.01%	2337
2024 Q4	$4.83K	Buy	244 +82	+51%	+$1.87K	﹤0.01%	2286
2024 Q3	$4.05K	Buy	+162	New	+$3.95K	﹤0.01%	2257
2024 Q2	–	Sell	-58	Closed	-$1.14K	–	2956
2024 Q1	$1.14K	Buy	58 +28	+93%	+$547	﹤0.01%	2344
2023 Q4	$526	Hold	30	–	–	﹤0.01%	2393
2023 Q3	$521	Hold	30	–	–	﹤0.01%	2522
2023 Q2	$422	Sell	30 -13	-30%	-$174	﹤0.01%	2596
2023 Q1	$0	Hold	43	–	–	﹤0.01%	2605
2022 Q4	$1K	Hold	43	–	–	﹤0.01%	2458
2022 Q3	$1K	Buy	+43	New	+$490	﹤0.01%	2455
2022 Q1	–	Sell	-7,622	Closed	-$86K	–	2370
2021 Q4	$86K	Buy	+7,622	New	+$93.7K	﹤0.01%	1574
2021 Q1	–	Sell	-4,000	Closed	-$71K	–	2307
2020 Q4	$71K	Buy	+4,000	New	+$70.3K	﹤0.01%	1878

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Nisa Investment Advisors's KNSA Position: Q2 2026 in Review

Nisa Investment Advisors increased its Kiniksa Pharmaceuticals (KNSA) stake by 590% in Q2 2026, buying an estimated $32.2K and bringing the position to 725 shares worth $46.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1887.

Nisa Investment Advisors first reported a position in KNSA in Q4 2020 and has held it in 17 quarters since. The position peaked at $86K in Q4 2021. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Nisa Investment Advisors held 725 shares of Kiniksa Pharmaceuticals worth $46.4K as of Q2 2026.
Nisa Investment Advisors bought 620 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $32.2K.
Kiniksa Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1887 holding.
Nisa Investment Advisors first reported a position in Kiniksa Pharmaceuticals in Q4 2020 and has held it in 17 quarters since.
Nisa Investment Advisors's Kiniksa Pharmaceuticals position peaked at $86K in Q4 2021.
266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.